UK Markets close in 3 hrs 45 mins

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
7,713.00+68.00 (+0.89%)
As of 12:30PM GMT. Market open.
Currency in GBp

Valuation measures

Market cap (intra-day) 5101.25B
Enterprise value 3117.9B
Trailing P/E 40.59
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)3.91
Price/book (mrq)829.80
Enterprise value/revenue 34.56
Enterprise value/EBITDA 615.30

Trading information

Stock price history

Beta (5Y monthly) 0.21
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 310,120.00
52-week low 35,871.00
50-day moving average 37,606.18
200-day moving average 38,215.57

Share statistics

Avg vol (3-month) 32.77M
Avg vol (10-day) 33.05M
Shares outstanding 51.31B
Float 1.31B
% held by insiders 10.32%
% held by institutions 152.95%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.16
Forward annual dividend yield 42.83%
Trailing annual dividend rate 32.80
Trailing annual dividend yield 30.04%
5-year average dividend yield 43.74
Payout ratio 4147.69%
Dividend date 3N/A
Ex-dividend date 413 Aug 2020
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)30 Sep 2020

Profitability

Profit margin 9.65%
Operating margin (ttm)19.86%

Management effectiveness

Return on assets (ttm)5.22%
Return on equity (ttm)17.71%

Income statement

Revenue (ttm)25.87B
Revenue per share (ttm)19.72
Quarterly revenue growth (yoy)2.70%
Gross profit (ttm)19.54B
EBITDA 7.7B
Net income avi to common (ttm)2.5B
Diluted EPS (ttm)190.00
Quarterly earnings growth (yoy)116.70%

Balance sheet

Total cash (mrq)8.45B
Total cash per share (mrq)6.44
Total debt (mrq)24.62B
Total debt/equity (mrq)180.78
Current ratio (mrq)0.96
Book value per share (mrq)9.30

Cash flow statement

Operating cash flow (ttm)4.38B
Levered free cash flow (ttm)4.98B